About AventaMed
AventaMed is a company based in Cork (Ireland) founded in 2013 by Keith Jansen, John Vaughan, and Olive Odriscoll was acquired by Karl Storz in February 2023. AventaMed has raised $3.58 million across 4 funding rounds from investors including Enterprise Ireland, Karl Storz and HBAN. AventaMed offers products and services including Solo+ ™. AventaMed operates in a competitive market with competitors including Preceptis Medical, NousQ, Tympanogen, Doya Medical and EntraTympanic, among others.
- Headquarter Cork, Ireland
- Founders Keith Jansen, John Vaughan, Olive Odriscoll
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aventamed Dac
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.58 M (USD)
in 4 rounds
-
Latest Funding Round
$2.12 M (USD), Angel Round
Oct 20, 2017
-
Investors
Enterprise Ireland
& 3 more
-
Employee Count
Not available
-
Acquired by
Karl Storz
(Feb 08, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AventaMed
AventaMed offers a comprehensive portfolio of products and services, including Solo+ ™.
Device for quick ear tube insertion using topical anesthesia.
People of AventaMed
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of AventaMed
AventaMed has successfully raised a total of $3.58M across 4 strategic funding rounds. The most recent funding activity was a Angel Round of $2.12 million completed in October 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in AventaMed
AventaMed has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Enterprise Ireland, Karl Storz and HBAN.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A platform connecting angel investors to startups in Ireland.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Support is provided to Irish manufacturing and service sector businesses.
|
Locked | Locked | Locked |
Investor details for AventaMed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AventaMed
Investment portfolio details for AventaMed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AventaMed
Detailed financials for AventaMed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aventamed Comparisons
Peer comparison for AventaMed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AventaMed
AventaMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Preceptis Medical, NousQ, Tympanogen, Doya Medical and EntraTympanic, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Surgical tools for pediatric ear tube procedures are developed.
|
|
| Locked | Locked | Locked |
Developer of a robotic surgical applicator for ear tube surgery. This device aims to simplify the procedure, reducing the need for general anesthesia and a surgical microscope. It enables outpatient settings and potentially reduces costs. The applicator uses commercially available ear tubes and features safety and precision enhancements through robotics and sensor technology. It makes a precise incision on the eardrum, improving outcomes for patients.
|
|
| Locked | Locked | Locked |
Provider of gel patch for chronic tympanic membrane perforations
|
|
| Locked | Locked | Locked |
Develops non-invasive stent technology for treating otitis media with effusion.
|
|
| Locked | Locked | Locked |
Medical device for the treatment of middle ear infections
|
Detailed competitors of AventaMed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aventamed
Complete news archive for AventaMed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AventaMed
AventaMed was founded in 2013 and raised its 1st funding round 1 year after it was founded.
AventaMed is headquartered in Cork, Ireland.
Keith Jansen is the current CEO of AventaMed. They have also founded this company.
AventaMed is a funded company, having raised a total of $3.58M across 4 funding rounds to date.
AventaMed is developing surgical devices, initially focused on a device which allows safe placement of ear tubes or grommets in an out-patient setting. Grommets are used to surgically treat Otitis Media with Effusion, which is a build up of fluid behind the ear drum. Was spun out from the MEDIC research centre, Cork Institute of Technology.
AventaMed's top competitors include Preceptis Medical, Tympanogen and NousQ.
AventaMed offers Solo+ ™.
AventaMed has 4 investors. Key investors include Enterprise Ireland, Karl Storz, HBAN, and Irrus Investments.